American Thoracic Society Quick-Reference GUIDELINES Apps
Issue link: https://eguideline.guidelinecentral.com/i/528960
Disclaimer is Guideline attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. is Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Abbreviations ATS, American oracic Society; EIB, exercise-induced bronchoconstriction; FEV1, forced expiratory volume in one second; ICS, inhaled corticosteroid; inh, inhalation; LABA, long- acting β 2 -agonist; LTRA, leukotriene receptor antagonist; MCS, mast cell stabilizing agent; NAEPP, National Asthma Education and Prevention Program; SABA, short-acting β-agonist Source Parsons JP, Hallstrand TS, Mastronarde JG, et al. An Official American oracic Society Clinical Practice Guideline: Exercise-induced Bronchoconstriction. Am J Respir Crit Care Med. 187990:1016-1027. 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 For additional copies, order at GuidelineCentral.com Copyright © 2015 All rights reserved ATSEIB15043 References 1. Accolate ® [package insert]. Wilmington DE: AstraZeneca LP; 2013. 2. Aerobid ® [package insert]. St. Louis, MO: Forest Pharmaceuticals, Inc.; 2002. 3. Alvesco ® [package insert]. Marlborough, MA: Sunovion Pharmaceuticals Inc.; USA 2013. 4. Arnuity Ellipta [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2014. 5. Asmanex Twisthaler [package insert]. Whitehouse Station NJ: Merck Sharp & Dohme Corp. Whitehouse Station NJ; 2011. 6. Atrovent HFA ® [package insert]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc.; 2012. 7. Azmacort [package insert]. Cranbury, NJ: Kos Pharmaceuticals, Inc.; 2007. 8. Flovent Diskus [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2014. 9. Flovent HFA [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2014. 10. Intal ® [package insert]. Bridgewater, NJ: Aventis Pharmaceuticals Inc.; 2003 11. Maxair ® [package insert]. Scottsdale, AZ: Medicis; 2011. 12. National Asthma Education and Prevention Program. National Heart, Lung, Blood Institute. National Institutes of Health. Guidelines for the Diagnosis and Management of Asthma (EPR-3). Available at: http://www.nhlbi.nih.gov/health-pro/guidelines/current/asthma-guidelines/full- report. Accesssed: April 9, 2015. 13. ProAir HFA ® [package insert]. Horsham, PA: Teva Respiratory, LLC; 2012. 14. Proventil HFA ® [package insert]. Whitehouse Station NJ: Merck Sharp & Dohme Corp.; 2012. 15. Proventil ® [package insert]. Whitehouse Station NJ: Merck Sharp & Dohme Corp.; 2012. 16. Proventil ® HFA [package insert]. Whitehouse Station NJ: Merck Sharp & Dohme Corp.; 2012. 17. Pulmicort Flexhaler [package insert]. Wilmington DE: AstraZeneca LP; 2013. 18. Pulmicort Respules ® [package insert]. Wilmington DE: AstraZeneca LP; 2010. 19. QVAR ® [package insert]. Teva Respiratory, LLC; 2014. 20. Singulair ® [package insert]. Whitehouse Station NJ: Merck Sharp & Dohme Corp.; 2012. 21. Tilade ® [package insert]. Bristol, TN: King Pharmaceuticals, Inc., 2005. 22. Ventolin HFA ® [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2014. 23. Xopenex HFA ® [package insert]. Marlborough, MA: Sunovion Pharmaceuticals Inc.; 2012. 24. Xopenex ® [package insert]. Marlborough, MA: Sunovion Pharmaceuticals Inc.; 2013. 25. Zyflo CR ® ) [package insert]. Cary, NC: Chiesi USA, Inc. 2014.